PAVM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PAVmed Inc. (PAVM) is not a good buy for a beginner investor with a long-term strategy. The company's financial performance is extremely poor, with significant revenue and net income declines. There are no positive catalysts, and technical indicators suggest no strong upward momentum. Additionally, options data and trading sentiment are neutral, and there is no recent news or influential trading activity to support a bullish case.
The MACD is slightly positive, indicating weak upward momentum. RSI is neutral at 61.187, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 9.914, with resistance at 10.77 and support at 9.059. Overall, technical indicators do not provide a strong buy signal.
NULL identified. There is no recent news, no significant insider or hedge fund activity, and no congress trading data.
Gross margin remains negative despite a YoY increase. Additionally, the stock has a 60% chance of declining slightly in the next day and week.
In Q3 2025, revenue dropped to $5,000 (-99.50% YoY), net income fell to -$6,328,000 (-109.84% YoY), and EPS declined to -8.81 (-120.38% YoY). Gross margin increased to -1000, but remains negative. Overall, financial performance is extremely weak.
No analyst ratings or price target changes are available for PAVmed Inc. at this time.
